The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic.

Slides:



Advertisements
Similar presentations
A Simplified Procedure for Hematopoietic Stem Cell Amplification Using a Serum-Free, Feeder Cell-Free Culture System Ian M. Rogers, Nobuko Yamanaka, Robert.
Advertisements

What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance by Marta Palomo, Enrique Mir, Montse Rovira,
Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation  Sarah J. Kizilbash, Clifford E. Kashtan,
Adverse Clinical Consequences of Hyperglycemia from Total Parenteral Nutrition Exposure during Hematopoietic Stem Cell Transplantation  Patricia M. Sheean,
Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns 
Comparison of Unmobilized and Mobilized Graft Characteristics and the Implications of Cell Subsets on Autologous and Allogeneic Transplantation Outcomes 
Differential effects of orbital and laminar shear stress on endothelial cells  Alan Dardik, MD, PhD, Leiling Chen, MD, Jared Frattini, MD, Hidenori Asada,
How to Treat MDS without Stem Cell Transplantation
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation  David Stephen Shulman, Wendy B. London, Dongjing.
Allogeneic Hematopoietic Cell Transplantation May Alleviate the Negative Prognostic Impact of Monosomal and Complex Karyotypes on Patients with Acute.
Vaccination of Children following Allogeneic Stem Cell Transplantation
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Peter Hurley, Suma Konety, Qing Cao, Daniel Weisdorf, Anne Blaes 
Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation  Yuan.
Defibrotide Prevents the Activation of Macrovascular and Microvascular Endothelia Caused by Soluble Factors Released to Blood by Autologous Hematopoietic.
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,
Allogeneic Stem Cell Transplantation in Myelofibrosis
Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients  Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon.
Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns 
Adverse Clinical Consequences of Hyperglycemia from Total Parenteral Nutrition Exposure during Hematopoietic Stem Cell Transplantation  Patricia M. Sheean,
Characterizing Donor-Derived Cells in Nonhematopoietic Tissue
Sabina Kersting, Leo F. Verdonck 
Vascular Endothelial Growth Factor and Activin-A Serum Levels Following Allogeneic Hematopoietic Stem Cell Transplantation  David Nachbaur, Petra Schumacher,
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: Role of the Conditioning Regimen and the Type of Transplantation  Marta Palomo,
Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?  Jason W. Chien, Keith M. Sullivan  Biology.
Betty T. Tran, Abigail Halperin, Jason W. Chien 
Caroline F. Morrison, Donna M
Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation in Children  Coco de Koning, Maud Plantinga, Paul Besseling, Jaap Jan Boelens,
Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation  Jessica T. Stover,
Effect of retroviral transduction on human endothelial cell phenotype and adhesion to Dacron vascular grafts  Ronald J. Jankowski, MS, Donald A. Severyn,
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation  Anita D'Souza,
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
Anemia Associated with Impaired Erythropoietin Secretion after Allogeneic Stem Cell Transplantation: Incidence, Risk Factors, and Response to Treatment 
Improvement of Pulmonary Function with Imatinib Mesylate in Bronchiolitis Obliterans Following Allogeneic Hematopoietic Cell Transplantation  Navneet.
Visualizing the Immune Synapse
Nasal Epithelial Cells of Donor Origin after Allogeneic Hematopoietic Cell Transplantation are Generated at a Faster Rate in the First 3 Months Compared.
Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen  Anu Korula,
Is There a Role for Autologous Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia? A Retrospective Analysis  Nicolas Novitzky, Valda.
Incidence, Predisposing Factors, and Outcome of Engraftment Syndrome in Pediatric Allogeneic Stem Cell Transplant Recipients  Irene Schmid, Daniel Stachel,
Pharmacokinetic Evaluation of the Drug Interaction between Intravenous Itraconazole and Intravenous Tacrolimus or Intravenous Cyclosporin A in Allogeneic.
Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Rammurti.
Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck 
Allogeneic Stem Cell Transplantation for Aplastic Anemia
Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation  Sarah J. Kizilbash, Clifford E. Kashtan,
Haploidentical/Mismatched Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for T Cell Acute Lymphoblastic Leukemia  Yu Wang,
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Gerard Socié, K. Scott Baker, Smita Bhatia 
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation  Mohammed M. Elayan, Justin G.
What is quality in a transplant program?
Volume 57, Issue 5, Pages (May 2000)
Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance  Deborah.
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
Blood and Marrow Transplant Handbook
A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome  Peggy A. Wu,
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Better Prognosis Than Systemic Relapse 
John Koreth, Edwin P. Alyea, William J. Murphy, Lisbeth A. Welniak 
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Distinct Deleterious Effects of Cyclosporine and Tacrolimus and Combined Tacrolimus– Sirolimus on Endothelial Cells: Protective Effect of Defibrotide 
Monitoring Mixed Lineage Leukemia Expression May Help Identify Patients with Mixed Lineage Leukemia–Rearranged Acute Leukemia Who Are at High Risk of.
Yuri Fedoriw, T. Danielle Samulski, Allison M. Deal, Cherie H
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Treatment versus Transplant for Challenging Hematologic Disorders
Altered Functional Status of the Hypothalamic Dopaminergic Tone in Patients with Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?
Presentation transcript:

The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms  Marta Palomo, Maribel Diaz-Ricart, Carla Carbo, Montserrat Rovira, Francesc Fernandez-Aviles, Gines Escolar, Günther Eissner, Ernst Holler, Enric Carreras  Biology of Blood and Marrow Transplantation  Volume 15, Issue 5, Pages 537-546 (May 2009) DOI: 10.1016/j.bbmt.2009.01.013 Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Cell growth and morphological changes. Light micrographs showing EC monlayers grown in the presence of control sera (A) and sera collected from patients in the auto group at day 14 (B) and from patients in the allo group at day 21 (C). The images correspond to semiconfluent monolayers. The arrows point out differences in cell morphology and the presence of detritus in (B) and (C), respectively. These micrographs are representative of 6 different experiments. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Expression of VCAM-1, ICAM-1, and E-selectin on the surface of ECs. Light micrographs (original magnification, ×320 for all micrographs) show EC monolayers grown in the presence of sera from controls (A and D), from patients in the auto group at day 14 (B and E), and from patients in the allo group at day 21 (C and F). Micrographs (D), (E), and (F) correspond to images captured with the epi-polarizing filter to visualize VCAM-1 expression and are representative of 6 different experiments. Bar diagrams represent the density of gold labeling (pixels/μm2; mean ± SEM; n = 6), corresponding to the expression of the adhesion receptors VCAM-1, ICAM-1, and E-selectin in cells grown with sera from patients in the auto group (G) and the allo group (H). ∗P < .05 versus Pre condition. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Adhesion of leukocytes on ECs exposed to blood under flow conditions. Light micrographs (original magnification, ×320 for all micrographs) showing leukocytes (arrows) adhered to ECMs grown in the presence of control sera (A), sera from patients in the auto group at day 14 (B), and sera from patients in the allo group at day 21 (C). The bar diagrams represent data corresponding to the adhesion of leucocytes, expressed as a percentage with respect to the number of ECs (number of leukocytes/100 ECs; mean ± SEM; n = 6) grown with sera from patients in the auto group (D) and the allo group (E). The dotted line represents the mean value for control results. ∗P < .05 versus Pre condition. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Platelet adhesion on ECMs generated by ECs. Light micrographs (original magnification, ×320 for all) show platelet interaction with ECM from cells grown in the presence of control sera (A) and sera from patients in the auto group at day 14 (B) and from those in the allo group at day 21 (C). Images are representative of 6 different experiments. Perfusion experiments were performed with citrated blood at 800 s-1 for 5 minutes. Bar diagrams represent the percentage of surface covered by platelets (%SC) expressed as mean ± SEM (n = 6 on the ECM generated by EC grown with sera from patients in the auto group (D) and the allo group (E)). The dotted line represents the mean value for control results. ∗P < .05 versus Pre condition #P < .05 versus control. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 vWF concentrations on ECMs from EC monolayers evaluated by immunocytochemistry using gold staining. The bar diagrams represent the expression of vWF (gold particles/μm2) on ECMs generated by EC monolayers grown in the presence of sera from patients in the auto group (A) and the allo group (B). Values are mean ± SEM (n = 6). ∗P < .05. The dotted line represents the mean value for control results. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 Phosphorylation kinetics of p38 MAPK, SAPK/JNK, and Erk 42/44. (A) Phosphorylation kinetics of p38MAPK and SAPK/JNK in cells exposed to control sera and sera from patients in the auto group at day 14 and from patients in the allo group at day 21, for 0 seconds, 30 seconds, and 5 minutes. (B) Phosphorylation kinetics of Erk42/44 after 30-second exposure of cells to the sera samples collected at the different time points, as indicated. Blots showing equal amounts of p38MAPK, SAPK/JNK, and Erk42/44 are presented under each phosphorylated protein. The blots are representative of 6 different experiments. Biology of Blood and Marrow Transplantation 2009 15, 537-546DOI: (10.1016/j.bbmt.2009.01.013) Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions